中国P站

Obesity; Adipose tissue; Gut microbiota; Epigenetics; Hypothalamic inflammation; Metabolic dysfunction; Mitochondrial dysfunction; Exosomes; Neuroinflammation; Type 2 diabetes

Introduction

Adipose tissue is increasingly recognized for its critical function as an active endocrine organ, engaging in intricate communication networks with vital organs such as the liver, muscle, and brain. This essential crosstalk is pivotal for maintaining metabolic homeostasis, and a significant body of research indicates that disruptions within these communication pathways are central to the development of widespread systemic metabolic dysfunction, a hallmark of obesity [1].

The gut microbiota plays a fundamental role in human health, and alterations in its composition and function are strongly implicated in the pathogenesis and progression of several metabolic disorders. Specifically, research has detailed how these microbial community changes contribute to conditions like obesity, type 2 diabetes, and nonalcoholic fatty liver disease. The influence extends to specific microbial taxa and their metabolic byproducts, which directly affect host metabolism [2].

Beyond direct genetic predisposition, epigenetic modifications, such as DNA methylation and histone acetylation, are key regulators that profoundly influence gene expression in the context of obesity. These mechanisms represent a dynamic interface where environmental factors interact with an individual's genetic makeup, shaping their metabolic phenotype. Understanding these epigenetic pathways is crucial for identifying potential therapeutic targets to combat obesity [3].

The brain's role in regulating appetite and energy expenditure is paramount, and chronic inflammation within the hypothalamus is a significant contributor to the pathogenesis of obesity. This process, which often involves the activation of microglia, leads to altered metabolic control. Hypothalamic inflammation explains how neural dysregulation can drive weight gain and broader metabolic dysfunction [4].

Adipose tissue function can be severely compromised by fibrosis, a process characterized by excessive accumulation of extracellular matrix proteins. This pathological remodeling impairs the normal functionality of fat tissue, directly contributing to insulin resistance and a spectrum of metabolic disorders seen in obesity. Investigating the underlying cellular and molecular mechanisms driving this fibrosis is essential for developing interventions [5].

Brown and beige adipose tissues hold considerable therapeutic promise due to their unique thermogenic capacities, which involve dissipating energy as heat. A comprehensive understanding of their biology, including the molecular mechanisms governing their differentiation and activation, is crucial. Harnessing the potential of these fat types could offer novel strategies for treating obesity and related metabolic conditions [6].

Mitochondrial dysfunction is a pervasive issue in various metabolic diseases, significantly contributing to the development of insulin resistance, fatty liver, and other complications associated with obesity. Impaired oxidative phosphorylation and increased production of reactive oxygen species within mitochondria are key factors in this dysfunction, highlighting mitochondria as central players in metabolic health [7].

The gut microbiota not only influences disease progression but also produces a variety of metabolites that impact host metabolism. Key examples include short-chain fatty acids and bile acids, which act as important signaling molecules. These metabolites significantly influence energy homeostasis and are critically reviewed for their role in obesity and metabolic syndrome [8].

Neuroinflammation within the central nervous system represents another critical aspect of obesity pathogenesis. This involves the activation of glial cells and the release of inflammatory mediators, which collectively disrupt normal appetite control and metabolic regulation. Elucidating these mechanisms offers promising avenues for novel therapeutic targets to address obesity-related neuroinflammation [9].

Emerging research highlights the significant role of exosomes, which are small extracellular vesicles, in mediating intercellular communication. These vesicles carry diverse molecular cargo, including proteins, lipids, and nucleic acids, influencing crucial physiological processes like insulin sensitivity, inflammation, and adipogenesis. Their involvement in obesity and metabolic syndrome underscores their potential as diagnostic markers or therapeutic targets [10].

Description

Obesity is a complex, multifactorial disease involving intricate biological systems. Research has thoroughly examined the critical role of adipose tissue, not merely as an energy storage site, but as a dynamic endocrine organ. Its sophisticated communication with organs such as the liver, muscle, and brain is vital for metabolic regulation. Disturbances in this intercellular crosstalk are directly implicated in systemic metabolic dysfunction characteristic of obesity [1]. Furthermore, pathological changes like adipose tissue fibrosis, marked by excessive extracellular matrix accumulation, significantly impair fat tissue function, thereby contributing to insulin resistance and other metabolic disorders in obese individuals [5]. Conversely, the thermogenic capacities of brown and beige adipose tissues present promising avenues for therapeutic intervention. Understanding their differentiation and activation mechanisms is key to developing future strategies against obesity [6].

The gut microbiota emerges as a powerful modulator of host metabolism. Alterations in its composition and function are strongly linked to the development and progression of obesity, type 2 diabetes, and nonalcoholic fatty liver disease. Specific microbial taxa and their metabolic byproducts have been identified as key influencers of host metabolism [2]. Expanding on this, microbiota-derived metabolites, such as short-chain fatty acids and bile acids, act as critical signaling molecules. These substances profoundly affect energy homeostasis, and their impact on obesity and metabolic syndrome is a significant area of study [8].

Central nervous system involvement, particularly inflammation, is another critical aspect of obesity. Hypothalamic inflammation, driven by microglia, plays a crucial role in the pathogenesis of obesity by disrupting brain regions that regulate appetite and energy expenditure, leading to weight gain and metabolic dysregulation [4]. This phenomenon extends to broader neuroinflammation, where glial cell activation and the release of inflammatory mediators in the central nervous system contribute to altered appetite control and systemic metabolic dysfunction, offering new targets for therapeutic intervention [9].

At a cellular and molecular level, epigenetic modifications, including DNA methylation and histone acetylation, are pivotal in influencing gene expression related to obesity. These modifications highlight how environmental factors interact with genetic predispositions through flexible epigenetic pathways, thereby identifying potential therapeutic targets [3]. Mitochondrial dysfunction, characterized by impaired oxidative phosphorylation and increased reactive oxygen species, also significantly contributes to insulin resistance, fatty liver, and other metabolic complications observed in obesity [7]. Moreover, exosomes, which are small extracellular vesicles, play an emerging role in mediating intercellular communication in obesity and metabolic syndrome. They carry molecular cargo that can influence insulin sensitivity, inflammation, and adipogenesis, underscoring their potential as mediators and therapeutic targets [10]. This comprehensive body of research collectively illustrates the multifaceted nature of obesity and points towards diverse biological pathways for intervention.

Conclusion

Obesity is a multifaceted metabolic disorder driven by complex interactions across various biological systems. Adipose tissue, functioning as an active endocrine organ, plays a critical role through its intricate crosstalk with distant organs like the liver, muscle, and brain; disruptions in these communication networks are central to systemic metabolic dysfunction characteristic of obesity [1]. Beyond its endocrine functions, adipose tissue can undergo pathological changes like fibrosis, where excessive extracellular matrix accumulation impairs its normal function, contributing to insulin resistance and other metabolic complications [5]. However, brown and beige adipose tissues, with their thermogenic capacities, offer promising therapeutic avenues for energy expenditure, and their development and activation mechanisms are subjects of active research [6]. The gut microbiota profoundly influences obesity development and progression. Alterations in its composition contribute to conditions such as type 2 diabetes and nonalcoholic fatty liver disease, with specific microbial taxa and their metabolic byproducts directly impacting host metabolism [2]. These gut microbiota-derived metabolites, including short-chain fatty acids and bile acids, act as crucial signaling molecules that influence energy homeostasis in the context of obesity and metabolic syndrome [8]. Inflammation also emerges as a key pathological contributor in obesity. Hypothalamic inflammation, particularly involving microglia, disrupts brain regions regulating appetite and energy expenditure, leading to weight gain [4]. This concept extends to broader neuroinflammation, where glial cell activation and inflammatory mediator release in the central nervous system contribute to altered appetite control and metabolic dysfunction [9]. Further molecular insights reveal that epigenetic modifications, such as DNA methylation and histone acetylation, profoundly influence gene expression in obesity, linking environmental factors with genetic predispositions and identifying therapeutic targets [3]. Similarly, mitochondrial dysfunction, characterized by impaired oxidative phosphorylation and increased reactive oxygen species, significantly contributes to insulin resistance and fatty liver in obesity [7]. Lastly, exosomes, small extracellular vesicles, mediate intercellular communication by carrying molecular cargo that influences insulin sensitivity, inflammation, and adipogenesis, highlighting their emerging role in obesity and metabolic syndrome [10]. This collective body of research underscores the intricate and interconnected biological pathways underpinning obesity.

References

1. Zhaoliang L, Minyi W, Junjie X (2024) .Trends Endocrinol Metab 35:43-57.

   , ,

2. Ziyuan Z, Bo P, Jiahui D (2023) .Front Microbiol 14:1276020.

   , ,

3. Jun-Chao C, Yu-Feng Z, Yan-Ping H (2023) .Mol Metab 77:101804.

   , ,

4. Ana LS, Maria CZ, Manuel MdlF (2022) .Mol Metab 63:101538.

   , ,

5. Yi W, Yan L, Yanan P (2022) .Obes Rev 23:e13470.

   , ,

6. Shweta S, Anup K, Vinod K (2021) .J Cell Physiol 236:8133-8149.

   , ,

7. Xinyu W, Yu H, Ying Z (2021) .Cell Death Dis 12:114.

   , ,

8. Yue W, Na L, Dongbo L (2020) .Trends Endocrinol Metab 31:840-850.

   , ,

9. Sara B, Inmaculada M, Carolina E (2020) .Int J Mol Sci 21:7076.

   , ,

10. Jianbo Z, Mengyuan S, Jie L (2019) .Diabetes Res Clin Pract 153:1-9.

    , ,